Legal

Disclaimer

Last updated 28 June 2026

This page applies to all information published by Boson Ventures Pty Ltd on boson.vc and its subdomains, including all fund pages, performance figures, portfolio descriptions, insights, and marketing collateral.

1. About Boson Ventures

Boson Ventures Pty Ltd (Boson Ventures) is an Australian holding company headquartered in Melbourne. Boson Ventures, through its subsidiaries described below, operates Boson Newton Fund II as an Early Stage Venture Capital Limited Partnership (ESVCLP) registered with Innovation and Science Australia under the Venture Capital Act 2002 (Cth).

Boson Health Tech VC Pty Ltd ACN 662 619 383 (Boson Health) is a corporate authorised representative (CAR Number 74472211) of Sagestone Asset Management Pty Ltd ACN 621 697 621 (Sagestone) AFSL 700034. Boson Health Tech VC Pty Ltd and Sagestone Asset Management Pty Ltd are both subsidiaries of Boson Ventures. Nothing on this site constitutes the provision of personal financial product advice.

2. Wholesale investors only

Investment opportunities described on this site — including any reference to Boson Newton Fund II or Boson Eoarchean Fund I — are available only to persons who qualify as wholesale clients or sophisticated investors under sections 708 and 761G of the Corporations Act 2001 (Cth). Retail investors are not eligible and should not rely on any information presented here as an offer.

3. Performance figures

Where performance metrics are presented (including TVPI, DPI, IRR, and individual portfolio company multiples), these figures are calculated in accordance with International Private Equity and Venture Capital Valuation (IPEV) Guidelines and reflect Boson Ventures' assessment of fair value at the stated reporting date. Performance figures are unaudited.

A material proportion of value remains unrealised. Realised returns may differ from current valuations. Past performance is not indicative of future results.

4. Forward-looking statements

Statements on this site that describe future events, market opportunities, investment theses, fund strategies, or expected returns are forward-looking. Forward-looking statements involve known and unknown risks, uncertainties, and assumptions. Actual results may differ materially. Boson Ventures undertakes no obligation to update forward-looking statements to reflect subsequent events.

5. ESVCLP tax concessions

References to a 10% non-refundable tax offset and 0% capital gains tax treatment relate to the ESVCLP tax concessions available under Australian law as at the date of this disclaimer. Tax outcomes depend on the individual circumstances of each investor and may change. Investors should obtain independent tax advice before investing.

6. Portfolio company information

Descriptions of portfolio companies are provided for informational purposes only and do not constitute investment recommendations or offers to invest in those companies directly. Boson Ventures may hold positions in companies named on this site.

7. Confidentiality

More detailed fund documentation, including the Information Memorandum, Limited Partnership Agreement, and subscription documents, is provided only to qualifying prospective investors under non-disclosure arrangements. Information on this site is a summary and should not be relied upon for investment decisions.

8. Contact

Investor enquiries: ir@boson.vc
Media enquiries: media@boson.vc
General: hello@boson.vc

Boson Ventures Pty Ltd · Melbourne · Sydney
Authorised via Boson Health Tech VC Pty Ltd ACN 662 619 383 (CAR 74472211) of Sagestone Asset Management Pty Ltd ACN 621 697 621 (AFSL 700034)